These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30887132)

  • 1. Ophthalmic Drug Discovery and Development.
    Gukasyan HJ; Hailu S; Karami TK
    Pharm Res; 2019 Mar; 36(5):69. PubMed ID: 30887132
    [No Abstract]   [Full Text] [Related]  

  • 2. Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology.
    Rowe-Rendleman CL
    Pharm Res; 2019 Feb; 36(4):54. PubMed ID: 30790065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic opportunities for the medicinal chemist.
    Kador PF
    Future Med Chem; 2012 Nov; 4(17):2127-9. PubMed ID: 23190097
    [No Abstract]   [Full Text] [Related]  

  • 4. Collaboration or competition: Take your pick.
    Novack GD
    Ocul Surf; 2019 Oct; 17(4):833-837. PubMed ID: 31505265
    [No Abstract]   [Full Text] [Related]  

  • 5. Keep your eyes open: challenges and opportunities in ophthalmic therapeutics.
    Wang S
    Future Med Chem; 2012 Nov; 4(17):2119-21. PubMed ID: 23190095
    [No Abstract]   [Full Text] [Related]  

  • 6. How Well Are We Applying Quantitative Methods to Reverse Translation to Inform Early Clinical Development?
    Heatherington AC; Kasichayanula S; Venkatakrishnan K
    Clin Pharmacol Ther; 2018 Feb; 103(2):174-176. PubMed ID: 29274086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to rekindle drug discovery process through integrative therapeutic targeting?
    Vaidya A; Roy A; Chaguturu R
    Expert Opin Drug Discov; 2018 Oct; 13(10):893-898. PubMed ID: 30146919
    [No Abstract]   [Full Text] [Related]  

  • 8. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2017 Jun; 33(5):335-336. PubMed ID: 28441083
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient-Centered Reverse Translation.
    Wagner JA
    Clin Pharmacol Ther; 2018 Feb; 103(2):168-170. PubMed ID: 29210055
    [No Abstract]   [Full Text] [Related]  

  • 10. How to utilize academic research efforts in cancer drug discovery.
    Bérubé G
    Expert Opin Drug Discov; 2019 Apr; 14(4):331-334. PubMed ID: 30784328
    [No Abstract]   [Full Text] [Related]  

  • 11. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2014 Jun; 30(5):371-2. PubMed ID: 24897062
    [No Abstract]   [Full Text] [Related]  

  • 12. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):701. PubMed ID: 24073621
    [No Abstract]   [Full Text] [Related]  

  • 13. Developing and sustaining India's capacity for preclinical drug discovery.
    Lewis DI; Patel BK; Kumar BD; Medhi B
    Indian J Pharmacol; 2018; 50(5):225-226. PubMed ID: 30636824
    [No Abstract]   [Full Text] [Related]  

  • 14. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2014 Oct; 30(8):603-4. PubMed ID: 25280174
    [No Abstract]   [Full Text] [Related]  

  • 15. The need for pharmacovigilance in ophthalmic practice.
    Natarajan S
    Indian J Ophthalmol; 2016 Mar; 64(3):175-6. PubMed ID: 27146926
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives on the Role of Mathematics in Drug Discovery and Development.
    Allen R; Moore H
    Bull Math Biol; 2019 Sep; 81(9):3425-3435. PubMed ID: 30693431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. George Yancopoulos.
    Nat Rev Drug Discov; 2018 Mar; 17(4):234-235. PubMed ID: 29588518
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial drug discovery: lessons of history and future strategies.
    Travis A; Chernova O; Chernov V; Aminov R
    Expert Opin Drug Discov; 2018 Nov; 13(11):983-985. PubMed ID: 30136874
    [No Abstract]   [Full Text] [Related]  

  • 19. Aviv Regev.
    Mullard A
    Nat Rev Drug Discov; 2021 Apr; 20(4):256-257. PubMed ID: 33731922
    [No Abstract]   [Full Text] [Related]  

  • 20. Success of ophthalmic pharmaceutical start-up companies.
    Stewart WC; Kruft B; Nelson LA; Stewart JA
    Acta Ophthalmol; 2018 Mar; 96(2):e266-e268. PubMed ID: 29068525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.